Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of maraviroc in HIV-1 infected subjects receiving novel antigen immunisation
2008-006769-95Phase 4Terminated
- Sponsor
- St Stephen's AIDS Trust
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing Maraviroc arm with Placebo arm (2 arms). Primary endpoint: Change in tetanus antibody titres following vaccination. Started Apr 2009; status: terminated.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-006769-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006769-95.